Medicine’s Donald VanDevanter comments on new cystic fibrosis medication

FDA grants priority review to potential antibiotic for pulmonary flares in CF

Cystic Fibrosis Today: Donald VanDevanter, adjunct professor of pediatrics, discussed a new medication under review by the FDA that could potentially alleviate symptoms of cystic fibrosis.